[1]张治建,顾峥荣,王玺.踝关节镜下微骨折术联合富血小板血浆治疗距骨软骨损伤40例[J].中国中医骨伤科杂志,2025,33(06):81-83+87.[doi:10.20085/j.cnki.issn1005-0205.250614]
　ZHANG Zhijian,GU Zhengrong,WANG Xi.Clinical Observation on 40 Cases of Talus Cartilage Injury Treated with Ankle Arthroscopic Microfracture Surgery in Conjunction with Platelet-Rich Plasma[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(06):81-83+87.[doi:10.20085/j.cnki.issn1005-0205.250614]
点击复制

踝关节镜下微骨折术联合富血小板血浆治疗距骨软骨损伤40例()

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年06期
页码:
81-83+87
栏目:
临床报道
出版日期:
2025-06-15

文章信息/Info

Title:
Clinical Observation on 40 Cases of Talus Cartilage Injury Treated with Ankle Arthroscopic Microfracture Surgery in Conjunction with Platelet-Rich Plasma
文章编号:
1005-0205(2025)06-0081-03
作者:
张治建1; 顾峥荣1; 王玺1
1广安市广安区人民医院(四川 广安,638500)
Author(s):
ZHANG Zhijian1; GU Zhengrong1; WANG Xi1
1Guang'an District People's Hospital of Guang'an City,Guang'an 638500,Sichuan China.
关键词:
距骨软骨损伤;  关节镜;  微骨折术;  富血小板血浆
Keywords:
cartilage injury of the talus;  arthroscopy;  microfracture;  platelet-rich plasma
分类号:
R681.8
DOI:
10.20085/j.cnki.issn1005-0205.250614
文献标志码:
B
摘要:
目的:观察经关节镜下微骨折术联合富血小板血浆治疗距骨软骨损伤的效果。方法:2022年3月至2023年3月经体格检查及影像学检查明确诊断的40例距骨软骨损伤患者,均行关节镜下微骨折术联合踝关节腔内注射自体富血小板血浆治疗。结果:患者术后随访12个月以上,无感染,无神经损伤。所有患者术后6个月及12个月的疼痛视觉模拟量表(VAS)评分明显低于术前,差异有统计学意义(P<0.05); 与术后6个月的患者相比,术后12个月患者VAS评分均有不同程度降低,差异有统计学意义(P<0.05)。患者术后6个月及12个月美国足踝外科协会(AOFAS)评分明显高于术前,差异有统计学意义(P<0.05); 与术后6个月的患者相比,术后12个月患者AOFAS评分均有不同程度提高,差异有统计学意义(P<0.05)。结论:关节镜下微骨折术联合踝关节腔注射富血小板血浆治疗距骨软骨损伤能够明显改善患者的踝关节功能,减轻患者的疼痛感,且安全性高。
Abstract:
Objective:The aim of this study is to observe the clinical efficacy of arthroscopic microfracture surgery in conjunction with platelet-rich plasma in the treatment of talus cartilage injury.Methods:From March 2022 to March 2023,we included 40 cases of talus cartilage injury,which were definitively diagnosed through physical examination and imaging studies.40 cases were treated with arthroscopic microfracture in conjunction with intra-ankle injection of autologous platelet-rich plasma.Results:All 40 patients were followed for a minimum of 12 months,and no postoperative complications,such as infection or nerve injury,were reported in any of the patients.The pain visual analogue scale(VAS)scores of all 40 patients were significantly lower than those before surgery at 6 months and 12 months postoperatively(P<0.05).Compared with the patients at 6 months postoperatively,the VAS scores of the patients at 12 months postoperatively decreased to different degrees(P<0.05).The American orthopaedic foot and ankle society(AOFAS)scores of the patients at 6 months and 12 months after surgery were significantly higher than those before surgery(P<0.05).Compared with the patients at 6 months after surgery,the AOFAS scores of the patients at 12 months after surgery were significantly improved(P<0.05).Conclusion:The efficacy of arthroscopic microfracture surgery,when in conjunction with injection of platelet-rich plasma into the ankle joint cavity for the treatment of talus cartilage injury,is superior to that of arthroscopic microfracture surgery alone.This combined approach merits clinical promotion and application.

参考文献/References:

[1] KERKHOFFS G M M J,KARLSSON J.Osteochondral lesions of the talus[J].Knee Surg Sports Traumatol Arthrosc,2019,27(9):2719-2720.
[2] EASLEY M E,LATT L D,SANTANGELO J R,et al.Osteochondral lesions of the talus[J].J Am Acad Orthop Surg,2020,18(10):616-630.
[3] SAVAGE-ELLIOTT I,ROSS K A,SMYTH N A,et al.Osteochondral lesions of the talus:a current concepts review and evidence-based treatment paradigm[J].Foot Ankle Spec,2022,7(5):414-422.
[4] DEKKER T J,STEELE J R,FEDERER A E,et al.Efficacy of particulated juvenile cartilage allograft transplantation for osteochondral lesions of the talus[J].Foot Ankle Int,2018,39(3):278-283.
[5] HEPPLE S,WINSON I G,GLEW D.Osteochondral lesions of the talus:a revised classification[J].Foot Ankle Int,1999,20(12):789-793.
[6] POWERS R T,DOWD T C,GIZA E.Surgical treatment for osteochondral lesions of the talus[J].Arthroscopy,2021,37(12):3393-3396.
[7] CANALE S T,BELDING R H.Osteochondral lesions of the talus[J].J Bone Joint Surg:Am Vol,1980,62(1):97-102.
[8] BASCIANI S,LONGO U G,PAPALIA G F.Arthroscopic microfracture and associated techniques in the treatment of osteochondral lesions of the talus:a systematic review and meta-nalysis[J].Foot Ankle Surg,2024,30(3):219-225.
[9] FERKEL R D,FLANNIGAN B D,ELKINS B S.Magnetic resonance imaging of the foot and ankle:correlation of normal anatomy with pathologic conditions[J].Foot Ankle,2021,11(2):289-305.
[10] 刘鸽,陈强,褚忠君.人纤维蛋白原的临床应用研究进展[J].中国输血杂志,2021,34(8):935-938.
[11] MEI-DAN O,CARMONT M R,LAVER L,et al.Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus[J].Am J Sports Med,2022,40(3):534-541.

更新日期/Last Update: 2025-06-15